Sandbox:Sara.Zand

TRICUSPID ATRESIA

overview

Tricuspid atresia is the third most common cyanotic congenital heart disease in which the non oxygenate blood can not flow from right artrium to right ventricle due to non development or agenesia of tricuspid valve. Right ventricle is small and pulmonary artery in some cases is stenotic.

Majority of infants with die in the first year of life without surgery. ASD or PFO are necessary for passing the blood from right atrium to left system and with out them the infants will not survive.

Historical perspective

Tricuspid atresia was first discovered by friedrich ludwig kreysig in 1817, a German physician who found the obstruction between right atrium and right ventricle . The classic term of tricuspid atresia was used firstly by schuberg in 1861.

Pathophysiology

Inferior vena cava and superior vena cava collect venous non oxygenate blood into right atrium. Through ASD blood reach to left atrium and finally flow into left ventricle and via aorta artery goes into the rest of body. This blood is the mixture of saturated and unsaturated oxygen. If there is VSD, this mixed blood in left ventricle come into right ventricle via VSD , then via pulmonary artery flows into pulmonary bed and becomes oxygenate ,then returns back into left atrium with pulmonary venous oxygenate blood . If the pulmonary blood flow deminished flow is dependent on PDA, the mixed blood in aora flow from this passage into pulmonary artery and pulmonary bed.

In the presence of normal positioning of great arteries cyanosis is more prominent and is affected by the size of VSD .TGA and subaortic stenosis and persistent left superior vena cava are others associated anomalies

Classification

Tricuspid atresia is classified according to connection between ventricles with great arteries(aorta, pulmonary) into two subgroups:

• ·        Normal connection between ventricles and  aorta and pulmonary artery . this type is much more common and consistence 70%-80% of cases.Most patients are cyanotic.

• ·        Aorta comes from small  right ventricle and pulmonary artery comes from left ventricle. Heart failure and pulmonary hypertension are common . Systemic Flow in aorta is dependent on VSD size . Subaortic stenosis and aortic arch anomalies are common

Differentiating tricuspid atresia from other Diseases

• Tricuspid atresia must be differentiated from other diseases that cause lung olygemia and cyanosis , such as

• TS
• PS
• ASD
• TOF

Epidemiology and Demographics[edit | edit source]

• The prevalence of tricuspid atresia is approximately 1.2 per 100,00 birth live.

Age

• tricuspid atresia is more commonly observed among infant less than one year old.

Gender

• Tricuspid atresia affects male and female equally.

Race

• There is no racial predilection for tricuspid atresia

Risk Factors[edit | edit source]

• there is no specific risk factors for occurance of tricuspid atresia during pregnancy .
• few cases were reported as inheritance autosomal recessive tricuspid atresia

Natural History, Complications and Prognosis[edit | edit source]

• Early clinical features in infants include cyanosis of lips and tongue, difficulty in breathing, tiring easily during feeding
• severity of cyanosis in infants with pulmonary stenosis is dependent on the amount of pulmonary blood flow passing through patent dactus arteriosis .After physiologic clousure PDA , the cyanosis will aggravate.
• in patients with relative normal pulmonary blood flow complicatios of heart failure is common
• Prognosis is generally [excellent/good/poor], and the [1/5/10­year mortality/survival rate] of patients with [disease name] is approximately [#%].

Diagnosis[edit | edit source]

Diagnostic Criteria[edit | edit source]

• The diagnosis of [disease name] is made when at least [number] of the following [number] diagnostic criteria are met:

• [criterion 1]
• [criterion 2]
• [criterion 3]
• [criterion 4]

Symptoms[edit | edit source]

• [Disease name] is usually asymptomatic.
• Symptoms of [disease name] may include the following:

• [symptom 1]
• [symptom 2]
• [symptom 3]
• [symptom 4]
• [symptom 5]
• [symptom 6]

Physical Examination

• Patients with pulmonary stenosis and closed PAD usually appear cyanotic after birth.
• Physical examination may be remarkable for:

• Normal pulses
• Deminished right ventricle impulse
• Thrill due to VSD or severe PS
• Holosystolic murmure in LSB due to VSD
• Continuous murmur of PDA ,occasionally
• Systolic ejection murmur in left uper sternal border due to PS
• clubbing in older patients and unrepaired disease.
  

Patients with high pulmonary blood flow without stenosis and with VSD are not cyanitic at birth.

physical examination may be remarkable for signs AND SYMPTOMS of overt heart failure:

• Tachypnea
• poor feeding
• poor growth

Laboratory Findings[edit | edit source]

• There are no specific laboratory findings associated with [disease name].

• A [positive/negative] [test name] is diagnostic of [disease name].
• is diagnostic of [disease name].
• Other laboratory findings consistent with the diagnosis of [disease name] include [abnormal test 1], [abnormal test 2], and [abnormal test 3].

Imaging Findings[edit | edit source]

• Echocardiography is the imaging modality of choice for tricuspid atresia and can show ASD, VSD, PDA, and aortic arch anomaly.
• On EKG, tricuspid atresia is characterized by left axis deviation, left ventricle hypertrophy, right atrium enlargment and left atrium enlargment in increment amount of of pulmonary blood flow.
• CXR may demonestrate situs solitus, left sided aortic arch ,levocardia, absent main pulmonary artery, heart size is dependent on pulmonary blood flow, right aortic arch in %25 of cases.
• Catheterization may demonestrate the gradient between left ventricle and right aventricle in subaortic stenosis.

Treatment[edit | edit source]

Medical Therapy[edit | edit source]

• There is no treatment for [disease name]; the mainstay of therapy is supportive care.

• The mainstay of therapy for [disease name] is [medical therapy 1] and [medical therapy 2].
• [Medical therapy 1] acts by [mechanism of action 1].
• Response to [medical therapy 1] can be monitored with [test/physical finding/imaging] every [frequency/duration].

Surgery[edit | edit source]

• Surgery is the mainstay of therapy for tricuspid atresia.

·        In first 8 weeks of life if there is  severe cyanosis and  normal connection ventricles with aorta and pulmonary artery , making a shunt between systemic to pulmonary circulation is suitable.

• ·        If pulmonary artery comes from left ventricle, PA banding is useful for loweing the pulmonary blood flow

• ·        In older children, bidirection Glenn shunt which is the connection between superior venacava to pulmonary artery is done for transferring the blood to pulmonary bed.

Prevention[edit | edit source]

• There are no primary preventive measures available for [disease name].

• Effective measures for the primary prevention of [disease name] include [measure1], [measure2], and [measure3].

• Once diagnosed and successfully treated, patients with [disease name] are followed-up every [duration]. Follow-up testing includes [test 1], [test 2], and [test 3].

References

1.Svensson EC, Huggins GS, Lin H, et al. A syndrome of tricuspid atresia in mice with a targeted mutation of the gene encoding Fog-2. Nat Genet. 2000;25(3):353-356. doi:10.1038/77146